◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › I › ITGR

Integer Holdings Corp (ITGR) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-08-23

Integer Holdings Corp (ITGR) operates in the MEDICAL DEVICES industry and is headquartered in Plano, United States with about 11,000 employees. Its market capitalization is roughly $4 billion. In the fiscal year ended 2025-12-31, ITGR reported $1.8B in revenue and $103M in net income.

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.

Interactive charts & full statements → Open the ITGR valuation workbench →

ITGR Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$1.8B	$1.8B	$1.7B	$1.6B	$1.3B	$1.2B	$1.1B	$1.3B	$1.2B	$1.1B	$1.1B	$800M	$688M	$664M	$646M	$569M	$533M	$522M	$547M	$319M	$271M
Gross Profit	$437M	$426M	$461M	$412M	$347M	$337M	$286M	$355M	$363M	$354M	$338M	$258M	$232M	$219M	$202M	$180M	$174M	$166M	$156M	$116M	$102M
Gross Margin %	23.7%	23.1%	26.9%	26.5%	26.0%	27.6%	26.6%	28.2%	29.8%	31.2%	31.4%	32.2%	33.7%	33.0%	31.3%	31.7%	32.5%	31.9%	28.5%	36.4%	37.8%
Operating Income (EBIT)	$174M	$209M	$208M	$163M	$113M	$136M	$121M	$158M	$156M	$126M	$93M	$13M	$76M	$61M	$69M	$62M	$69M	$1M	$35M	$20M	$22M
Operating Margin %	9.5%	11.3%	12.1%	10.5%	8.5%	11.1%	11.2%	12.5%	12.8%	11.1%	8.6%	1.6%	11.0%	9.2%	10.6%	10.8%	12.9%	0.2%	6.4%	6.3%	8.2%
Net Income	$128M	$103M	$120M	$91M	$66M	$97M	$77M	$96M	$168M	$67M	$6M	($8M)	$55M	$36M	($5M)	$33M	$33M	($9M)	$19M	$15M	$16M
Net Margin %	7.0%	5.6%	7.0%	5.8%	5.0%	7.9%	7.2%	7.7%	13.8%	5.9%	0.5%	-0.9%	8.1%	5.5%	-0.7%	5.8%	6.2%	-1.7%	3.4%	4.7%	5.9%
EBITDA	$313M	$294M	$333M	$276M	$222M	$225M	$183M	$247M	$253M	$244M	$228M	$152M	$131M	$112M	$115M	$102M	$104M	$49M	$93M	$62M	$47M
Earnings Per Share (EPS)	$3.67	$2.89	$3.36	$2.69	$1.99	$2.91	$2.33	$2.92	$5.15	$2.08	$0.19	$-0.29	$2.14	$1.43	$-0.20	$1.40	$1.39	$-0.39	$0.77	$0.67	$0.61
Shares Outstanding (M)	34M	36M	36M	34M	33M	33M	33M	33M	33M	32M	31M	26M	26M	25M	24M	24M	24M	23M	24M	22M	26M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ITGR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$464M	$440M	$471M	$467M	$473M	$436M	$449M	$431M
Gross Profit	$113M	$110M	$106M	$108M	$107M	$106M	$117M	$117M
Gross Margin %	24.3%	24.9%	22.5%	23.2%	22.7%	24.3%	26.0%	27.2%
Operating Income (EBIT)	$35M	$35M	$51M	$54M	$53M	$52M	$57M	$58M
Operating Margin %	7.4%	8.0%	10.8%	11.5%	11.2%	11.8%	12.7%	13.5%
Net Income	$24M	$17M	$49M	$40M	$37M	($23M)	$33M	$35M
Net Margin %	5.1%	3.8%	10.3%	8.5%	7.8%	-5.2%	7.3%	8.2%
EBITDA	$68M	$65M	$92M	$88M	$88M	$31M	$86M	$90M
Earnings Per Share (EPS)	$0.69	$0.48	$1.38	$1.11	$1.04	$-0.66	$0.90	$0.99
Shares Outstanding (M)	34M	34M	35M	36M	36M	34M	36M	36M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ITGR Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$205M	$196M	$205M	$180M	$116M	$157M	$181M	$165M	$167M	$149M	$106M	$12M	$81M	$57M	$65M	$90M	$77M	$72M	$57M	$43M	$39M
Capital Expenditures (CapEx)	$93M	$91M	$105M	$120M	$75M	$53M	$51M	$48M	$45M	$47M	$59M	$45M	$25M	$19M	$41M	$22M	$16M	$20M	$44M	$20M	$15M
Free Cash Flow (FCF)	$112M	$105M	$100M	$60M	$42M	$103M	$130M	$117M	$122M	$102M	$47M	($32M)	$56M	$38M	$24M	$67M	$61M	$52M	$13M	$23M	$24M
FCF Margin %	6.1%	5.7%	5.8%	3.9%	3.1%	8.5%	12.1%	9.3%	10.1%	9.0%	4.4%	-4.0%	8.2%	5.8%	3.7%	11.8%	11.4%	10.0%	2.4%	7.2%	8.8%
Dividends Paid	—	—	—	—	$3M	$4M	$1M	$0M	—	$0M	$0M	$7M	$0M	$0M	$0M	$0M	—	—	$142M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ITGR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$60M	$25M	$55M	$66M	$44M	$31M	$63M	$72M
Capital Expenditures (CapEx)	$23M	$24M	$27M	$19M	$19M	$25M	$19M	$26M
Free Cash Flow (FCF)	$37M	$1M	$28M	$46M	$25M	$6M	$44M	$45M
FCF Margin %	8.0%	0.2%	5.9%	9.9%	5.3%	1.4%	9.8%	10.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ITGR Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$3.4B	$3.4B	$3.1B	$2.9B	$2.8B	$2.6B	$2.4B	$2.4B	$2.3B	$2.8B	$2.8B	$3.0B	$956M	$891M	$890M	$881M	$777M	$831M	$849M	$664M	$548M
Cash & Cash Equivalents	$21M	$17M	$47M	$24M	$24M	$18M	$49M	$14M	$26M	$44M	$52M	$82M	$77M	$35M	$20M	$37M	$23M	$38M	$22M	$33M	$71M
Total Liabilities	$1.7B	$1.7B	$1.5B	$1.4B	$1.4B	$1.2B	$1.1B	$1.2B	$1.3B	$2.0B	$2.1B	$2.1B	$342M	$349M	$409M	$414M	$350M	$451M	$473M	$341M	$248M
Total Debt (Short + Long-Term)	$1.2B	$1.2B	$1.0B	$971M	$937M	$838M	$740M	$822M	$926M	$1.6B	$1.7B	$1.7B	$188M	$198M	$225M	$236M	$221M	$289M	$353M	$241M	$170M
Total Shareholders' Equity	$1.7B	$1.7B	$1.6B	$1.5B	$1.4B	$1.4B	$1.3B	$1.2B	$1.1B	$893M	$725M	$851M	$613M	$542M	$481M	$467M	$427M	$380M	$351M	$323M	$300M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ITGR viewer.

Other Companies in MEDICAL DEVICES

BIO.B · Bio-Rad Laboratories Inc — $10 billion
GKOS · Glaukos Corp — $10 billion
BRKR · Bruker Corporation — $9 billion
HAE · Haemonetics Corporation — $5 billion
LIVN · LivaNova PLC — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion
TMDX · TransMedics Group Inc — $3 billion
NEOG · Neogen Corporation — $3 billion

← ITG All “I” companies ITH →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.